The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Neurocrine Biosciences, Inc. (NASDAQ: NBIX) closed at $111.88 down -1.82% from its previous closing price of $113.95. In other words, the price has decreased by -$1.82 from its previous closing price. On the day, 1.32 million shares were traded. NBIX stock price reached its highest trading level at $114.05 during the session, while it also had its lowest trading level at $110.95.
Ratios:
For a deeper understanding of Neurocrine Biosciences, Inc.’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.87 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 22.84. For the most recent quarter (mrq), Quick Ratio is recorded 4.08 and its Current Ratio is at 4.19. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on August 29, 2024, Upgraded its rating to Overweight and sets its target price to $159 from $131 previously.
On April 24, 2024, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $140 to $170.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 13 ’24 when Boyer David W. sold 3,461 shares for $121.88 per share. The transaction valued at 421,828 led to the insider holds 1,672 shares of the business.
DAVID WARREN BOYER bought 4,756 shares of NBIX for $576,808 on Sep 13 ’24. On Aug 15 ’24, another insider, RASTETTER WILLIAM H, who serves as the Director of the company, sold 14,250 shares for $146.69 each. As a result, the insider received 2,090,332 and left with 37,491 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NBIX now has a Market Capitalization of 11517597696 and an Enterprise Value of 10549922816. As of this moment, Neurocrine’s Price-to-Earnings (P/E) ratio for their current fiscal year is 33.80, and their Forward P/E ratio for the next fiscal year is 16.27. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.03. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.33 while its Price-to-Book (P/B) ratio in mrq is 4.50. Its current Enterprise Value per Revenue stands at 4.978 whereas that against EBITDA is 18.528.
Stock Price History:
Over the past 52 weeks, NBIX has reached a high of $157.98, while it has fallen to a 52-week low of $103.63. The 50-Day Moving Average of the stock is -16.51%, while the 200-Day Moving Average is calculated to be -17.83%.
Shares Statistics:
For the past three months, NBIX has traded an average of 902.72K shares per day and 947090 over the past ten days. A total of 100.98M shares are outstanding, with a floating share count of 98.78M. Insiders hold about 2.17% of the company’s shares, while institutions hold 93.03% stake in the company. Shares short for NBIX as of 1726185600 were 2227530 with a Short Ratio of 2.47, compared to 1723680000 on 2285086. Therefore, it implies a Short% of Shares Outstanding of 2227530 and a Short% of Float of 2.5799999000000002.
